10 completed. 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
Follow Endostar: new trials by email Literature Review of Endostar trials Research Report on Endostar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis Endostar, standard SRILI treatment - Radiation Pneumonitis, Endostatin | Phase 2 | Completed | Xinqiao Hospital of Chongqing | 126 | 2018-09-01 | 2024-02-23 |
| Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas Irinotecan, DDP, Endostar - Esophageal Squamous Cell Carcinoma | Phase 2 | Completed | Fudan University | 52 | 2017-05-04 | 2025-07-23 |
| Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma Endostar, Placebo, AIM regimen / GT regimen - Soft Tissue Sarcoma, Adult, Stage IIB | Phase 2 | Completed | Tianjin Medical University Cancer Institute and Hospital | 52 | 2017-05-01 | 2019-12-26 |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma Endostar, DDP - Cervical Carcinoma | Phase 2 | Completed | Yong Zhang,MD | 120 | 2017-04-20 | 2025-07-29 |
| Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer Paclitaxel+Nedaplatin+Endostar - Esophageal Squamous Cell Carcinoma | Phase 2 | Completed | Yuhong Li | 52 | 2015-01-01 | 2023-02-16 |
| Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma endostar, DDP, IMRT - Nasopharyngeal Carcinoma | Phase 2 | Completed | First Affiliated Hospital of Guangxi Medical University | 120 | 2014-09-01 | 2022-02-14 |
| A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma endostar, intensity modulated radiation, cisplatin - Nasopharyngeal Neoplasms | Phase 2 | Completed | China Three Gorges University, Yichang, China | 75 | 2014-06-01 | 2020-06-24 |
| Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites Endostar, Cisplatin - Malignant Pleural Effusion, Malignant Ascites | Phase 2 | Completed | Jiangsu Simcere Pharmaceutical Co., Ltd. | 336 | 2011-03-01 | 2014-08-01 |
| Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) Endostar, Etoposide-Carboplatin - Small Cell Lung Cancer | Phase 2 | Completed | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | 138 | 2009-05-01 | 2014-09-03 |
| Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) Endostar, Vinorelbine, Cisplatin - Non-small Cell Lung Cancer | Phase 2 | Completed | Fudan University | 15 | 2008-12-01 | 2012-09-19 |
Esophageal Squamous Cell Carcinoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Neoplasms (1) · Pleural Effusion, Malignant (1) · Radiation Fibrosis Syndrome (1) · Radiation Pneumonitis (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Uterine Cervical Neoplasms (1)
Fudan University (2) · China Three Gorges University, Yichang, China (1) · First Affiliated Hospital of Guangxi Medical University (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Xinqiao Hospital of Chongqing (1) · Yong Zhang,MD (1) · Yuhong Li (1)
China (9)
Guoliang Jiang, MD (1) · Jilong Yang, M.D., Ph.D. (1) · Ming Fan, MD (1) · Shukui Qin, MD (1) · Shun Lu, Dr. (1) · Yong Zhang, MD (1) · Yu-hong Li, MD, Ph D (1)